Cargando…

A Novel Nomogram for Predicting Prognosis and Tailoring Local Therapy Decision for Ductal Carcinoma In Situ after Breast Conserving Surgery

Purpose: We sought to explore the role of nomogram-combined biomarkers, mammographic microcalcification and inflammatory hematologic markers in guiding local therapy decisions in ductal carcinoma in situ (DCIS) subgroups with different ipsilateral breast tumour recurrence (IBTR) risk. Methods: Betwe...

Descripción completa

Detalles Bibliográficos
Autores principales:	Xu, Feifei, Cao, Lu, Xu, Cheng, Cai, Gang, Cai, Rong, Qi, Weixiang, Wang, Shubei, Shen, Kunwei, Chai, Weimin, Chen, Jiayi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9456583/ https://www.ncbi.nlm.nih.gov/pubmed/36079116 http://dx.doi.org/10.3390/jcm11175188

Ejemplares similares

Nodal response to primary systemic therapy predicts prognosis of cN3c breast cancer patients receiving multimodality therapy
por: Li, Shuyan, et al.
Publicado: (2023)

Development and validation of an MRI-radiomics nomogram for the prognosis of pancreatic ductal adenocarcinoma
por: Xu, Xinsen, et al.
Publicado: (2023)

Is conservative management of ductal carcinoma in situ risky?
por: Zheng, Lan, et al.
Publicado: (2022)

Associations of clinicopathological factors with local treatment and survival outcome in elderly patients with ductal carcinoma in situ
por: Zhang, Xu, et al.
Publicado: (2023)

Comprehensive analysis of the 21-gene recurrence score in invasive ductal breast carcinoma with or without ductal carcinoma in situ component
por: Zeng, Yufei, et al.
Publicado: (2020)

Biologic behavior and long-term outcomes of breast ductal carcinoma in situ with microinvasion
por: Fang, Yan, et al.
Publicado: (2016)

An Updated Nomogram for Predicting Invasiveness in Preoperative Ductal Carcinoma In Situ of the Breast
por: Kim, Sanghwa, et al.
Publicado: (2019)

A clinical radiomics nomogram preoperatively to predict ductal carcinoma in situ with microinvasion in women with biopsy-confirmed ductal carcinoma in situ: a preliminary study
por: Huang, Zhou, et al.
Publicado: (2023)

Impact of multidisciplinary team on the pattern of care for brain metastasis from breast cancer
por: Xu, Fei, et al.
Publicado: (2023)

Prognostic and predictive significance of tumor infiltrating lymphocytes for ductal carcinoma in situ
por: Xu, Fei-Fei, et al.
Publicado: (2021)

Identification of aberrant gene expression during breast ductal carcinoma in situ progression to invasive ductal carcinoma
por: Song, Guiqin, et al.
Publicado: (2019)

Predictors of Recurrent Ductal Carcinoma In Situ after Breast-Conserving Surgery
por: Kim, Jung Yeon, et al.
Publicado: (2016)

The Clinical Utility of DCISionRT(®) on Radiation Therapy Decision Making in Patients with Ductal Carcinoma In Situ Following Breast-Conserving Surgery
por: Shah, Chirag, et al.
Publicado: (2021)

Pathological underestimation and biomarkers concordance rates in breast cancer patients diagnosed with ductal carcinoma in situ at preoperative biopsy
por: Zhou, Hemei, et al.
Publicado: (2022)

Clinicopathological characteristics and prognosis of triple-negative breast cancer invasive ductal carcinoma with ductal carcinoma in situ
por: Liu, Yang, et al.
Publicado: (2023)

Radiotherapy after Conservative Surgery in Ductal Carcinoma In Situ of the Breast: A Review
por: Amichetti, Maurizio, et al.
Publicado: (2012)

Impact of consensus guidelines for breast‐conserving surgery in patients with ductal carcinoma in situ
por: Tremelling, Abigail, et al.
Publicado: (2021)

Prognostic Factors and a Nomogram Predicting Survival in Patients with Breast Ductal Carcinoma in situ with Microinvasion: A Population-Based Study
por: Zheng, Yi-Zi, et al.
Publicado: (2021)

IMNI PRECISION trial protocol: a phase II, open-label, non-inferior randomized controlled trial of tailoring omission of internal mammary node irradiation for early-stage breast cancer
por: Qi, Wei-Xiang, et al.
Publicado: (2022)

Different distribution of breast ductal carcinoma in situ, ductal carcinoma in situ with microinvasion, and invasion breast cancer
por: Wei, Zhang, et al.
Publicado: (2012)

Molecular subtypes predict second breast events of ductal carcinoma in situ after breast‐conserving surgery
por: Yang, Yilan, et al.
Publicado: (2022)

Efficacy of breast MRI for surgical decision in patients with breast cancer: ductal carcinoma in situ versus invasive ductal carcinoma
por: Lee, Jeeyeon, et al.
Publicado: (2020)

Is radiotherapy necessary for intermediate risk ductal carcinoma in situ after breast conserving surgery?
por: Kim, Taeryung, et al.
Publicado: (2014)

Evaluation of automated breast volume scanner for breast conservation surgery in ductal carcinoma in situ
por: Huang, Anqian, et al.
Publicado: (2016)

Radiomics nomogram for the preoperative prediction of lymph node metastasis in pancreatic ductal adenocarcinoma
por: Bian, Yun, et al.
Publicado: (2022)

Development and external validation of a radiomics combined with clinical nomogram for preoperative prediction prognosis of resectable pancreatic ductal adenocarcinoma patients
por: Wang, Fangqing, et al.
Publicado: (2022)

Survival outcomes after breast-conserving surgery plus radiotherapy compared with mastectomy in breast ductal carcinoma in situ with microinvasion
por: Xia, Lin-Yu, et al.
Publicado: (2022)

Competing risk nomogram to predict cancer-specific survival in esophageal cancer during the intensity-modulated radiation therapy era: A single institute analysis
por: Zhao, Shengguang, et al.
Publicado: (2020)

Comparison of clinicopathological characteristics and prognosis among patients with pure invasive ductal carcinoma, invasive ductal carcinoma coexisted with invasive micropapillary carcinoma, and invasive ductal carcinoma coexisted with ductal carcinoma in situ: A retrospective cohort study
por: Guan, Xin, et al.
Publicado: (2020)

Development and Validation of Web-Based Nomograms to Predict Postoperative Invasive Component in Ductal Carcinoma in Situ at Needle Breast Biopsy
por: Lee, Seong Cheol, et al.
Publicado: (2014)

Analysis of Local Recurrence Risk in Ductal Carcinoma In Situ and External Validation of the Memorial Sloan Kettering Cancer Center Nomogram
por: Oses, Gabriela, et al.
Publicado: (2023)

Ductal carcinoma in situ (DCIS)
por: Holland, R
Publicado: (2002)

Ductal Carcinoma In Situ of the Breast
por: Lee, Richard J., et al.
Publicado: (2012)

Breast Ductal Carcinoma In Situ
por: Sacchini, Virgilio, et al.
Publicado: (2012)

Conservative treatment of breast ductal carcinoma in situ: results of an Italian multi-institutional retrospective study
por: Vidali, Cristiana, et al.
Publicado: (2012)

The Impact of Androgen Receptor and Histone Deacetylase 1 Expression on the Prognosis of Ductal Carcinoma In Situ
por: Lee, Choong Man, et al.
Publicado: (2020)

Characteristics, prognosis, risk factors, and management of recently diagnosed ductal carcinoma in situ with microinvasion
por: Li, Chunyan, et al.
Publicado: (2021)

Molecular subtyping reveals uniqueness of prognosis in breast ductal carcinoma in situ patients with lumpectomy
por: Yang, Libo, et al.
Publicado: (2022)

Tailoring atomic diffusion for in situ fabrication of different heterostructures
por: Zhang, Hui, et al.
Publicado: (2021)

The immune escape signature predicts the prognosis and immunotherapy sensitivity for pancreatic ductal adenocarcinoma
por: Lu, Hao, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_hg2vl9non7uvrb2lm5ms0kgecb